Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Anushree Tiku"'
Publikováno v:
Journal of Medical Case Reports, Vol 13, Iss 1, Pp 1-4 (2019)
Abstract Background Hypertension is common in pregnant women presenting with aortic coarctation or Takayasu’s arteritis. Uncontrolled hypertension leads to increased adverse maternal and neonatal events. Case presentation A 36-year-old gravida 2, p
Externí odkaz:
https://doaj.org/article/bada328eb3da439bab0aaca03e30b5eb
Publikováno v:
Current Opinion in Nephrology & Hypertension. 30:346-352
Purpose of review Several observational studies have shown that hyperuricemia is associated with chronic kidney disease (CKD) progression and is a potential therapeutic target in people with CKD. This review discusses the results of three recently pu
Autor:
Neil Boudville, Suetonia C. Palmer, Fiona G. Brown, Giles Walters, Richard O. Day, Graham R D Jones, Randall J. Faull, Robert J. Walker, Bettina Douglas, Elaine M. Pascoe, Philip Clarke, Vlado Perkovic, Anushree Tiku, Carmel M. Hawley, Donna Reidlinger, David W. Johnson, Ckd-Fix Study Investigators, Janak de Zoysa, David Harris, Alan Cass, John Kanellis, Sunil V. Badve, Laura Robison, Gopala K. Rangan, Nicola Dalbeth
Publikováno v:
New England Journal of Medicine. 382:2504-2513
Background Elevated serum urate levels are associated with progression of chronic kidney disease. Whether urate-lowering treatment with allopurinol can attenuate the decline of the estimat...
Autor:
Carinna Hockham, Lexia Bao, Anushree Tiku, Sunil V Badve, Aminu K Bello, Meg J Jardine, Vivekanand Jha, Tadashi Toyama, Mark Woodward, Min Jun
Publikováno v:
Clinical kidney journal. 15(6)
Background Previous reports on the prevalence of chronic kidney disease (CKD) in Asia have suggested important sex disparities but have been inconsistent in nature. We sought to synthesize available sex-disaggregated CKD prevalence data in Asia to qu
Publikováno v:
Current opinion in nephrology and hypertension. 30(3)
Several observational studies have shown that hyperuricemia is associated with chronic kidney disease (CKD) progression and is a potential therapeutic target in people with CKD. This review discusses the results of three recently published placebo-co
Publikováno v:
American journal of kidney diseases : the official journal of the National Kidney Foundation. 72(6)